State Ledger
Company profile

Quoin Pharmaceuticals Ltd. CIK 1671502

Ticker
QNRX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Ashburn, VA 20148-7349
Fiscal year end
2025 (FY)
Market Data
Close
$4.43
Change
-$0.16
Change %
-3.49%
Volume
743

QNRX · trading date Oct 12, 2026 · previous close $4.59 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$15.80M
Total assets
$20.39M
Total liabilities
$7.27M
Stockholders' equity
$13.12M
Cash & equivalents
$3.82M
Operating income
—
Operating cash flow
-$13.54M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
35.7%
Equity / assets
64.3%
CapEx / revenue
—
Operating cash flow / net income
0.86×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$15.80M $20.39M $7.27M $13.12M
2024 — -$8.96M $15.71M $6.50M $9.20M
2023 — -$8.69M $12.17M $6.51M $5.66M
2022 — -$9.38M $14.46M $7.05M $7.41M
2021 — -$21.46M $9.36M $8.70M $657.0K
Company Details
SIC code
2834
State of incorporation
L3
Active filer
Yes
Most recent SEC filing
Form S-3
2026-09-18
Financials filed via
Form 10-K
filed 2026-03-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Ashburn, VA 20148-7349
42127 PLEASANT FOREST COURT
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:00 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Virginia — Public Companies